Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
What factors would push you to consider using IMRT vs opposed lateral fields for a T2N0 glottic SCC?
Would having supraglottic extension lead you to use IMRT?
Answer from: Radiation Oncologist at Academic Institution
I use IMRT for all. IMRT should not cause recurrence if done correctly.
Sign In
or
Register
to read more
Answer from: Radiation Oncologist at Academic Institution
A low lying larynx where parallel opposed lateral fields and anterior oblique fields are not feasible.
Sign In
or
Register
to read more
2585
2579
Related Questions
In p16-positive oropharyngeal squamous cell carcinoma, when induction therapy is considered before definitive chemoradiation, how do you choose between a traditional TPF regimen and carboplatin/paclitaxel/pembrolizumab?
What GTV to CTV expansion do you utilize for NPC?
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
How would you approach a patient treated for a stage I glottic cancer 2 years prior with a biopsy proven recurrence who is declining surgery and any systemic therapy?
What's the role of contralateral neck re-irradiation in the post-op setting for someone with a remote history of head and neck cancer who underwent definitive RT with elective dose to the bilateral neck now with a new primary s/p surgery with ipsilateral neck dissection requiring post op chemo radiation for bony involvement and ENE?
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
What is the preferred neoadjuvant/adjuvant chemotherapy regimen for HPV-associated nasopharyngeal cancer?
How do you approach cisplatin dosing for locally advanced head and neck SCC in HPV-positive and HPV-negative patients?